ANAPTYSBIO INC
For the period ended Jun 12, 2024. Filed Apr 24, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 12, 2024 · Filed Apr 24, 2024
Contents
Cover page
Show cover page
DEF 14A 1 proxystatementfy2023_def14a.htm DEF 14A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No.)
| Filed by the Registrant | x | Filed by a Party other than the Registrant | ☐ |
|---|
Check the appropriate box:
| ¨ | Preliminary Proxy Statement |
|---|---|
| ¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☒ | Definitive Proxy Statement |
| ¨ | Definitive Additional Materials |
| ¨ | Soliciting Material Pursuant to §240.14a-12 |
(Name of Registrant as Specified In Its Charter)
N/A
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
| ☒ | No fee required. |
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
April 24, 2024
Dear Stockholder:
You are cordially invited to attend the 2024 Annual Meeting of Stockholders of AnaptysBio, Inc. to be held at AnaptysBio’s corporate office at 10770 Wateridge Circle, Suite 210, San Diego, CA 92121, on Wednesday, June 12, 2024 at 7:30 a.m. (Pacific Time).
The Securities and Exchange Commission rules allow companies to furnish proxy materials to stockholders over the Internet. We have elected to do so, thus reducing the environmental impact and lowering the costs of printing and distributing proxy materials without impacting your timely access to this important information. On or about April 24, 2024, we expect to mail to stockholders a Notice of Internet Availability of Proxy Materials containing instructions on how to access our proxy statement for our 2024 Annual Meeting of Stockholders and our annual report on Form 10-K for the year ended December 31, 2023 to stockholders. The Notice of Internet Availability or Proxy Materials also provides instructions on how to vote through the Internet or by telephone and includes instructions on how to receive paper copies of the proxy materials by mail, if desired.
The matters to be acted upon at the meeting are described in the accompanying notice of annual meeting and proxy statement.
Your vote is important.
Whether or not you plan to attend the meeting in person, please vote on the Internet or by telephone, or request, sign and return a proxy card to ensure that your shares are represented at the meeting.
Sincerely,
Daniel Faga
President and Chief Executive Officer
San Diego, California 92121
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
To Be Held Wednesday, June 12, 2024
To Our Stockholders:
NOTICE IS HEREBY GIVEN that the 2024 Annual Meeting of Stockholders of AnaptysBio, Inc. will be held at AnaptysBio’s corporate office at 10770 Wateridge Circle, Suite 210, San Diego, California 92121, on Wednesday, June 12, 2024 at 7:30 a.m. (Pacific Time).
We are holding the meeting for the following purposes, which are more fully described in the accompanying proxy statement:
To elect three Class I directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal.
To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.
To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials.
To approve the amendment and restatement of our 2017 Equity Incentive Plan (the “2017 Plan”).
In addition, stockholders may be asked to consider and vote upon such other business as may properly come before the meeting or any adjournment or postponement thereof.
Only stockholders of record at the close of business on April 15, 2024 are entitled to notice of, and to vote at, the meeting and any adjournments thereof. For ten days prior to the meeting, a complete list of the stockholders entitled to vote at the meeting will be available for examination by any stockholder for any purpose relating to the meeting during ordinary business hours at our headquarters.
Your vote as an AnaptysBio, Inc. stockholder is very important. Each share of stock that you own represents one vote.
Whether or not you expect to attend the meeting, we encourage you to read the proxy statement and vote through the Internet or by telephone, or request, sign and return your proxy card as soon as possible, so that your shares may be represented at the meeting. For specific instructions on how to vote your shares, please refer to the section entitled “General Information About the Meeting” in the proxy statement and the instructions on the Notice of Internet Availability of Proxy Materials. Only stockholders entitled to vote, or their duly authorized representatives, are entitled to attend the meeting. If you intend to attend the meeting in person, you must email info@anaptysbio.com no later than 5:00 p.m. on June 5, 2024 to confirm your attendance.
By Order of the Board of Directors,
John Orwin
Chairman of the Board of Directors
San Diego, California
April 24, 2024
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to be held on June 12, 2024: The Proxy Statement and our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 are available at http://ir.anaptysbio.com.
PROXY STATEMENT FOR 2024 ANNUAL MEETING OF STOCKHOLDERS
TABLE OF CONTENTS
| INFORMATION ABOUT SOLICITATION AND VOTING | 1 |
|---|---|
| INTERNET AVAILABILITY OF PROXY MATERIALS | 1 |
| GENERAL INFORMATION ABOUT THE MEETING | 1 |
| GENERAL PROXY INFORMATION | 2 |
| CORPORATE GOVERNANCE STANDARDS AND DIRECTOR INDEPENDENCE | 5 |
| PROPOSAL NO. 1 ELECTION OF CLASS I DIRECTORS | 10 |
| PROPOSAL NO. 2 RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | 15 |
| REPORT OF THE AUDIT COMMITTEE | 16 |
| PROPOSAL NO. 3 NON-BINDING ADVISORY VOTE ON COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS | 17 |
| PROPOSAL NO. 4 APPROVAL OF THE AMENDMENT AND RESTATEMENT OF 2017 EQUITY INCENTIVE PLAN | 18 |
| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT | 27 |
| EXECUTIVE OFFICERS | 29 |
| EXECUTIVE COMPENSATION TABLES | 38 |
| EQUITY COMPENSATION PLAN INFORMATION | 46 |
| CERTAIN RELATIONSHIPS AND RELATED-PARTY TRANSACTIONS | 47 |
| ADDITIONAL INFORMATION | 48 |
| OTHER MATTERS | 50 |
| ANNEX A | 51 |
i
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.